Bone engineering of the rabbit ulna.

Current bone grafting techniques face limitations in load-bearing environments. Autologous bone remains the gold standard but has donor site morbidity. Synthetic substitutes must balance mechanical strength with bioactivity. Prior research has shown that calcium phosphate ceramics support bone regeneration. However, controlled growth factor delivery remains a challenge. No prior work had resolved how to combine sustained release with structural integrity. This gap motivated the development of a new composite material. The need for a resorbable scaffold with bioactive properties is clear.

This study aimed to evaluate a new 3D porous silica-calcium phosphate nanocomposite. The goal was to assess its ability to deliver rhBMP-2 and regenerate bone in a weight-bearing defect. The researchers proposed to test the material in a rabbit ulna model. They wanted to compare the regenerated bone to natural bone in mechanical tests. The motivation was to find a substitute for autologous grafts. They focused on a 10-mm segmental defect in the ulna. The study sought to measure both structural and biological outcomes. The ultimate aim was to validate the material's potential for clinical use.

The team used rapid prototyping to shape SCPC powder into a bone replica. They coated the ceramic with rhBMP-2 before surgical implantation. A titanium plate was used to stabilize the graft in the defect. Bone healing was tracked using CT scans and histomorphometry. Biomechanical testing measured torsional strength after 12 weeks. In vitro studies assessed rhBMP-2 release and SCPC dissolution. Statistical comparisons were made between grafted and unoperated ulnae. The methods combined imaging, mechanical, and biochemical analyses.

CT scans after 4 weeks showed complete defect filling with new bone. Histology revealed mature bone morphology in the regenerated tissue. Torsional testing at 12 weeks showed restored mechanical strength. Maximum torque and angle at failure matched the contralateral ulna. The SCPC released rhBMP-2 effectively for 14 days in vitro. The sustained release profile correlated with enhanced bone formation. The regenerated bone demonstrated typical mechanical properties. The study suggests the hybrid material supports load-bearing repair.

The SCPC-rhBMP-2 hybrid showed promise in a rabbit ulna model. The material supported bone regeneration in a weight-bearing defect. The sustained rhBMP-2 release contributed to successful outcomes. The regenerated bone had both structural and biological similarity to natural bone. The study provides proof of principle for the hybrid's potential. The results suggest the material could replace autologous bone grafts. The combination of bioactivity and mechanical strength is notable. The authors propose further testing in larger animal models.